Besides, United States anesthesia drugs market is driven by factors, such as the growing geratic population, increasing incidence of cardiovascular cases, and rising number of urgent surgeries in the United States. Private and public health insurers like Aetna International, Anthem Blue Cross and Blue Shield, Medicare etc. are helping to boost this market by considering anesthetic drug in their reimbursement policy. As per the Research findings, United States Anesthesia Drugs Market will grow with a CAGR of 4% from 2021-2027.
Covid-19 Impact on the United States Anesthesia Drugs Industry:
The COVID-19 pandemic has significantly affected the United States anesthesia drugs market. The anesthesia drugs sector is seeing difficulties in the supply chain and manufacturing, such as attending to an uneven demand for products and delivering products to end-users on time. It can be attributed to the deterioration in the product demand from major end-users, inadequate surgeries in most hospitals, and interrupted supply chain and challenges in providing essential services due to lockdowns.
General Inhalation Anesthesia Drugs Market holds the Largest Market Share
On the basis of type, United States anesthesia drugs market includes General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market and Local Anesthesia Drugs Market. General Inhalation Anesthesia Drugs Market holds the largest market share, the inhaled anesthetics include sevoflurane, desflurane, isoflurane, and other are thought to enhance inhibitory postsynaptic channel activity and inhibit excitatory synaptic activity.
Further, general intravenous anesthesia is the leading segments in the United States anesthesia drug market. Benzodiazepines Class, Propofol, Ketamine, Methohexital Sodium, Fospropofol Disodium, Pentobarbital, Etomidate and Fentanyl are commonly used general intravenous anesthesia in the United States. Benzodiazepines and Propofol and Class are the leading anesthesia drugs among this anaesthesia.
United States Anesthesia Drugs Market Size was US$ 4.9 Billion in 2021
In the United States local anesthesia drugs market, bupivacaine is a prescription medicine utilized as a local anesthetic that prevents the nerve impulses that send pain signals to the brain. This medicine is a very useful anesthetic for regional and local anesthesia for several procedures, such as therapeutic, surgery and diagnostic and obstetrical procedures. It is used in various surgical procedures in the United States.
Major Players:
In the United States anesthesia drugs industry several players are selling their products. Most of the anesthesia drugs trade is generic, available at a low cost. The major drug companies working in this field are Baxter International Inc., Abbvie, Endo International plc, Draegerwerk AG, and Koninklijke Philips NV.
This latest Report "United States Anesthesia Drugs Market by Type (General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market and Local Anesthesia Drugs Market) by General Inhalation Anesthesia Drugs market (Benzodiazepines Class, Propofol, Ketamine, Methohexital Sodium, Fospropofol Disodium, Pentobarbital, Etomidate and Fentanyl) by General Intravenous Anesthesia Drugs Market (sevoflurane, desflurane, isoflurane, and other) by Local Anesthesia Drugs Market (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine, Other local anesthetics) by Company Analysis (Baxter International Inc., Abbvie, Endo International plc, Draegerwerk AG, and Koninklijke Philips NV)" provides complete details on United States Anesthesia Drugs Market.
Types - United States Anesthesia Drugs Market breakup by 3 viewpoints
1. General Intravenous Anesthesia Drugs Market
2. General Inhalation Anesthesia Drugs Market
3. Local Anesthesia Drugs Market
General Intravenous Anesthesia Drugs Market breakup by 8 viewpoints
1. Propofol
2. Benzodiazepines Class (Diazepam and Midazolam)
3. Fospropofol Disodium
4. Ketamine
5. Methohexital Sodium
6. Pentobarbital
7. Etomidate
8. Fentanyl
General Inhalation Anesthesia Drugs Market breakup by 4 viewpoints
1. Sevoflurane
2. Desflurane
3. Isoflurane
4. Others
Local Anesthesia Drugs Market breakup by 7 viewpoints
1. Bupivacaine
2. Ropivacaine
3. Lidocaine
4. Chloroprocaine
5. Prilocaine
6. Benzocaine
7. Other local anesthetics
Reimbursement Policy - United States Anesthesia Drugs Market breakup by 2 viewpoints
1. Private Health Insurance Providers
a) Aetna International
b) Coventry Health Care
c) Anthem Blue Cross and Blue Shield
d) Blue Cross and Blue Shield of Texas
e) United Healthcare
f) State Exceptions
2. Public Health Insurance Providers
a) Medicare
b) MDWise
All key players have been covered from 3 viewpoints
- Overview
- Recent Developments
- Revenue
Company Analysis:
1. Baxter International Inc.
2. Abbvie
3. Endo International plc
4. Draegerwerk AG
5. Koninklijke Philips NV
What is the estimated value of the U.S. Anesthesia Drugs Market?
What is the growth rate of the U.S. Anesthesia Drugs Market?
What is the forecasted size of the U.S. Anesthesia Drugs Market?
Who are the key companies in the U.S. Anesthesia Drugs Market?
Report Attribute | Details |
---|---|
No. of Pages | 155 |
Published | January 2022 |
Forecast Period | 2021 - 2027 |
Estimated Market Value ( USD | $ 4.9 Billion |
Forecasted Market Value ( USD | $ 6.2 Billion |
Compound Annual Growth Rate | 4.0% |
Regions Covered | United States |
No. of Companies Mentioned | 5 |
Table of Contents
Companies Mentioned
- Baxter International Inc.
- Abbvie
- Endo International plc
- Draegerwerk AG
- Koninklijke Philips NV
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...